ICOSLG and graft versus host disease: In murine models of GVHD, blockade of the ICOS:ICOSL interactions via moAb or ICOS−/− mice resulted in significant decrease in GVHD and GVHD related mortality both mediated by CD4+ and CD8+ cells (81).